ENSIGN GROUP INC/THE

Agwunobi John O’s routine sale of 392 Ensign Group (ENSG) shares at $171.06 shows a steady, non‑market‑reactive strategy, signaling long‑term confidence in the company’s health‑care trajectory.

Insider sale of 700 Ensign Group shares by director Barry M. Smith—under SEC 10b‑5‑1 plan—shows routine portfolio moves, not a warning, while company fundamentals stay strong.